Now live: Pro — the full 13F research suite for serious investorsSee pricing →
Atlas Venture Associates IX, LLC

Q2 2023 · 13F-HR

Atlas Venture Associates IX, LLCholdings as filed

Filed 2023-08-08 · accession 0001104659-23-088723

$18.3M
Reported value
6
Positions
2023-06-30
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
83067L109SKILLZ INC$10.4M57.0%1,145,492CommonSOLE
86877M209SURFUSDSURFACE ONCOLOGY INC$2.6M14.0%2,945,453CommonSOLE
84833T103SPROSPERO THERAPEUTICS INC$2.0M10.7%1,353,303CommonSOLE
83304A106SNAPSNAP INC$1.8M9.73%150,160CommonNONE
87166L100SYNLOGIC INC$1.1M6.24%2,651,963CommonSOLE
45826J105NTLAINTELLIA THERAPEUTICS INC$407,8002.23%10,000CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.